Compare HRL & RVTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HRL | RVTY |
|---|---|---|
| Founded | 1891 | 1937 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Meat/Poultry/Fish | Biotechnology: Laboratory Analytical Instruments |
| Sector | Consumer Staples | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.9B | 13.2B |
| IPO Year | N/A | N/A |
| Metric | HRL | RVTY |
|---|---|---|
| Price | $24.54 | $108.26 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 6 | 14 |
| Target Price | $28.00 | ★ $113.46 |
| AVG Volume (30 Days) | ★ 4.5M | 1.4M |
| Earning Date | 02-26-2026 | 02-02-2026 |
| Dividend Yield | ★ 4.79% | 0.26% |
| EPS Growth | N/A | ★ N/A |
| EPS | 0.87 | ★ 1.99 |
| Revenue | ★ $12,106,160,000.00 | $2,813,367,000.00 |
| Revenue This Year | $3.43 | $5.33 |
| Revenue Next Year | $2.24 | $3.03 |
| P/E Ratio | ★ $28.12 | $54.47 |
| Revenue Growth | 1.55 | ★ 3.37 |
| 52 Week Low | $21.03 | $81.36 |
| 52 Week High | $32.07 | $128.29 |
| Indicator | HRL | RVTY |
|---|---|---|
| Relative Strength Index (RSI) | 56.67 | 51.73 |
| Support Level | $24.37 | $110.17 |
| Resistance Level | $25.37 | $118.21 |
| Average True Range (ATR) | 0.60 | 4.19 |
| MACD | 0.05 | -0.64 |
| Stochastic Oscillator | 75.00 | 38.61 |
Historically meat-focused, Hormel Foods broadened its lineup to include other protein offerings and became a branded food company. The firm sells its wares through multiple channels, including US retail (61.6% of fiscal 2025 sales), US foodservice (32.6%), and international (5.9%). By product, 73% of fiscal 2025 sales were from perishable food and 27% from shelf-stable. Major brands include Hormel, Spam, Jennie-O, Columbus, Applegate, Planters, and Skippy. Many of these hold the number one or two market share in their respective categories.
Revvity is a global life sciences and diagnostics company formed in 2023 following the rebranding of PerkinElmer. The company operates in two segments: life sciences, which provides reagents and instruments for biopharma and academic research, and signals software, and diagnostics, which offers tools in immunodiagnostics and newborn and reproductive health. Revvity's products and services are sold worldwide, with major markets in the US, Europe, and China.